Check out our COVID-19 dedicated page for tenders related to medical equipment needs.

The Conference on the Future of Europe is your chance to share your ideas and shape the future of Europe. Make your voice heard!

Supplies - 320305-2020

08/07/2020    S130

United Kingdom-Sheffield: Ophthalmologicals

2020/S 130-320305

Prior information notice

This notice is for prior information only


Legal Basis:
Directive 2014/24/EU

Section I: Contracting authority

I.1)Name and addresses
Official name: The Collaborative Procurement Partnership LLP, OC415501 registered address 2150 Century Way Thorpe Park, Colton, Leeds, West Yorkshire, LS15 8ZB (acting on behalf of Supply Chain Coordination Ltd, 10881715 at Skipton House, 80 London Road, London, SE1 6LH
Postal address: NHS Supply Chain, CPP LLP, second Floor Don Valley House, Savile Street East
Town: Sheffield
Postal code: S4 7UQ
Country: United Kingdom
Contact person: Gail Humphreys
Telephone: +44 7790350662
Internet address(es):
Main address:
Address of the buyer profile:
I.2)Information about joint procurement
The contract is awarded by a central purchasing body
Additional information can be obtained from the abovementioned address
I.4)Type of the contracting authority
Body governed by public law
I.5)Main activity

Section II: Object

II.1)Scope of the procurement

Complete Ophthalmology Solutions 2 (COS 2)

Reference number: 1000011
II.1.2)Main CPV code
33662100 Ophthalmologicals
II.1.3)Type of contract
II.1.4)Short description:

The Collaborative Procurement Partnership (CPP LLP) acting on behalf of Supply Chain Coordination Ltd anticipates awarding a National Framework Agreement titled ‘Complete Ophthalmology Solutions 2’. The purpose of this framework is to offer the NHS an all-encompassing ophthalmology solution with all products available under one framework agreement to enable the NHS to get the most economical and advantageous route to market with an avenue to realise maximum potential on savings suppliers may bid for one or more lot(s) provided they can evidence the compliance criteria set out in the ITT.

Lot 1: Ophthalmic Equipment,

Lot 2: Ophthalmic Consumables and Implants.

Each lot is divided into sub-lots for ease of subject matter classification added value/additional offers will be considered in relation to each lot or across lots e.g. amortisation.

II.1.5)Estimated total value
Value excluding VAT: 300 000 000.00 GBP
II.1.6)Information about lots
This contract is divided into lots: yes
Maximum number of lots that may be awarded to one tenderer: 2

Ophthalmic Equipment

Lot No: 1
II.2.2)Additional CPV code(s)
33122000 Ophthalmology equipment
38634000 Optical microscopes
38000000 Laboratory, optical and precision equipments (excl. glasses)
33115000 Tomography devices
50344000 Repair and maintenance services of optical equipment
II.2.3)Place of performance
II.2.4)Description of the procurement:

Lot 1: Ophthalmic equipment

This lot is for the supply of ophthalmic equipment. The individual sub-lots are provided for ease of use by the NHS :

1.1) diagnostic — anterior,

1.2) diagnostic — posterior,

1.3) diagnostic — ultrasound,

1.4) surgical,

1.5) ophthalmic laser,

1.6) slit lamp equipment,

1.7) diabetic eye screening,

1.8) training equipment,

1.9) ophthalmic accessories and furniture.

II.2.14)Additional information

Ophthalmic equipment ranges from small handheld devices to capital equipment schemes warranty, repairs and maintenance are included within this lot.


Ophthalmic Consumables and Implants

Lot No: 2
II.2.2)Additional CPV code(s)
33731110 Intraocular lenses
33140000 Medical consumables
33141000 Disposable non-chemical medical consumables and haematological consumables
33169000 Surgical instruments
38636000 Specialist optical instruments
II.2.3)Place of performance
II.2.4)Description of the procurement:

Lot 2: Ophthalmic consumables and implants

This lot is for the supply of ophthalmic consumables and implants. The individual sub-lots are provided for ease of use by the NHS:

2.1) intraocular lenses (IOL’s),

2.2) ophthalmic surgical procedure packs,

2.3) ophthalmic instruments,

2.4) ophthalmic liquids, solutions and gases,

2.5) Glaucoma and ocular implants.

II.2.14)Additional information

Compliance to EU Regs on Medical Devices 2017/745 or the Human Tissue (Quality and Safety for Human Application) Regulations 2007 throughout the life of the framework agreement. A few products which fall outside of these regulative standards shall be evaluated and accepted as ‘sale by sample’ as detailed in the ITT.

II.3)Estimated date of publication of contract notice:

Section IV: Procedure

IV.1.8)Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: yes

Section VI: Complementary information

VI.3)Additional information:

The purpose of this notice is to advise potential bidders that the Collaborative Procurement Partnership LLP (CPP LLP) acting on behalf of Supply Chain Coordination Ltd SCCL intends to commence the tender process from 3 September 2020. Supplier events in support of this tender shall be conducted on the 8 and 9 September 2020 — the format of the events will be confirmed in the ITT (possible location is Sheffield) — please save one of these dates bidders’ attendance is recommended but not mandatory. The authority’s evaluation of any tender response you submit will not be affected by non-attendance. The eProcurement portal being used for this tender exercise is: potential bidders may express interest in this tender by email to: participating authorities entitled to use the resulting framework agreement, subject to the approval of SCCL/CPP LLP include:

• any NHS Trust, wholly owned NHS subsidiary, shared service, public sector purchasing or contracting authority:

— any other NHS/Public Sector bodies located in England, Wales, Scotland, Northern Ireland, including any of the Crown Dependencies and NHS Collaborative Procurement Organisations;

— the NHS in Wales, Scotland and Northern Ireland including but not limited to Primary care services — GPs, pharmacies, dentists and optometrists, Hospital services, and community services, including those provided through community health centres and mental health services at: NHS Wales (National Health Service for Wales): including but not limited to Welsh Health Boards, NHS Trusts and Public Health Wales o NHS Scotland (National Health Service for Scotland) including but not limited to Regional NHS Boards, Special NHS Boards and public health body

• any other NHS entity or local authority:

— the NHS in England (National Health Service for the United Kingdom) including but not limited to Foundation Trusts, Acute (Hospital) Trusts, Ambulance Trusts, Mental Health Trusts, Care Trusts;

— Social Enterprise UK, Local Authority Councils in England, Scotland and Wales: county, unitary, district, borough, and metropolitan councils (parish/community councils) Local Councils in England, Scotland and Wales, Local Authority Councils in Northern Ireland

• any government department agency or other statutory body:

— Clinical Commissioning Groups, Area Teams, Special Health Authorities, NHS Improvement, Department of Health, Arm’s Length Bodies, NHS England and other organisations involved in commissioning primary care services via Clinical Commissioning Groups supported by Commissioning Support Units which are responsible for commissioning most aspects of NHS care (or equivalent body) established pursuant to legislation enacted as a result of or in connection with, the White Paper, Equity and Excellence: Liberating the NHS published July 2010, CCG, CSU, The Clinical Commissioning Board, Area Teams and other organisations involved in commissioning and/or overseeing general practitioner services, GP consortia, GP Practices and any other provider of primary medical services:

(a) who are a party to any of the following contracts:

— General Medical Services (GMS),

— Personal Medical Services (PMS),

— Alternative Provider Medical Services (APMS); and/or

(b) commissioned by NHS England or other organisations involved in commissioning or overseeing general practitioner services, as described above.

• any third party/managed service acting on behalf of the NHS;

• two or more Public Sector Legal Entities acting collaboratively:

— Sustainability and Transformation Partnerships (STPs) and their individual constituent organisations.

VI.5)Date of dispatch of this notice: